ResearcherAnkara Numune Eğitim ve Araştırma HastanesiNo recent work listed
Nurullah Zengin
Matched on ORCID iD 0000-0002-5568-9904; OpenAlex author ID A5103047734. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 3)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 10
2012: 1 paper · 2013: none · 2014: 1 paper · 2015: none · 2016: none · 2017: 1 paper · 2018: 1 paper
Papers 4
- Comparison of Gemcitabine monotherapy with Gemcitabine and Cisplatin combination in metastatic pancreatic cancer: a retrospective analysis. Co-author PMID 30722120↗
- Is plasma caveolin-1 level a prognostic biomarker in metastatic pancreatic cancer? Last author DOI 10.4103/sjg.sjg_483_16↗
- Evaluation of the effect of comorbidity on survival in pancreatic cancer by using "Charlson Comorbidity Index" and "Cumulative Illness Rating Scale". Last author DOI 10.1007/s00508-013-0453-9↗
- Is there an association between blood group and survival in pancreatic cancer? Last author DOI 10.7314/apjcp.2012.13.12.6151↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Nuriye Özdemir · 3 shared papers, 2012–2018 · strength 0.14
- Paper Comparison of Gemcitabine monotherapy with Gemcitabine and Cisplatin combination in metastatic pancreatic cancer: a ret… PMID 30722120↗
- Paper Evaluation of the effect of comorbidity on survival in pancreatic cancer by using "Charlson Comorbidity Index" and "Cum… DOI 10.1007/s00508-013-0453-9↗
- Paper Is there an association between blood group and survival in pancreatic cancer? DOI 10.7314/apjcp.2012.13.12.6151↗
- Nebi Serkan Demirci · 2 shared papers, 2017–2018 · strength 0.13
- Doğan Uncu · 2 shared papers, 2012–2014 · strength 0.08
- Fahriye Tuğba Köş · 2 shared papers, 2012–2014 · strength 0.08
- Saadettin Kılıçkap · 1 shared paper, 2017 · strength 0.07
- Hüseyin Engin · 1 shared paper, 2018 · strength 0.07
- İsa Dede · 1 shared paper, 2018 · strength 0.07
- Elif Berna Köksoy · 1 shared paper, 2018 · strength 0.07
- Yüksel Ürün · 1 shared paper, 2018 · strength 0.07
- Yakup Ergün · 1 shared paper, 2018 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.